Teva Pharmaceutical Industries Ltd
Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –
Teva Pharmaceutical Industries Teva API Third-Party Sales by Quarter
Teva API Third-Party Sales — Local Currency YoY Change (%)
Teva Pharmaceutical Industries Teva API Third-Party Sales: -8.0% in Q3 2026, down 4.0 pts from a year earlier.
Where the Q3 2026 figure comes from
“API sales to third parties in the third quarter of 2026 were $115 million, a decrease of 8% in both U.S. dollars and local currency terms, compared to the third quarter of 2025. This decrease was mainly due to lower dema”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Teva API Third-Party Sales (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-tapi-yoy-lc
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?